Abstract

group, 10 (17%) in the alternative medication group. Immediate reactions were observed in 6 (10%) of all tested patients: anaphylaxis in 3 (5%), bronchospasm in 3 (5%). Two cases of anaphylaxis were observed in the first group, and only one in the second. Conclusions Most frequent adverse reactions were observed using ASA, while ketorolac and acetaminophen took the second place. True hypersensitivity was diagnosed for one fifth of the patients. Anaphylactic reactions to NSAID hypersensitivity appeared on 10% of them.

Highlights

  • Non-steroid anti-inflammatory drugs are one of accessible and most frequently used group of medications

  • Anaphylactic reactions induced by NSAID according to data of Vilnius University Hospital Santariskiu Klinikos

  • 244 patients addressed by general practitioners were consulted; female sex was predominant 68% (166 female). 444 different medications were mentioned in questionnaires. 182 (41%) of drugs were NSAIDs

Read more

Summary

Open Access

Olesia Gaidej1*, Gabija Didziokaite, Neringa Buterleviciute, Viktorija Paltarackiene, Gintare Nakrosyte, Ana Kozlovska, Laura Malinauskiene, Violeta Kvedariene. From 6th Drug Hypersensitivity Meeting (DHM 6) Bern, Switzerland. Non-steroid anti-inflammatory drugs are one of accessible and most frequently used group of medications. Severe and life-threatening reactions are a challenge for doctors and nurses of all specialities.

Methods
Results
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.